CYLD and amyotrophic lateral sclerosis: The missense variant in CYLD leads to alteration of CYLD immunoreactivity in the brain tissue [16], and shows two ALS-associated pathological phenotypes: an elevation of cytoplasmic TDP-43 level [57] and an impairment of autophagy function [58].